Inny tytuł:

Antisense Oligodeoxynucleotides: from the Bench to the Patient

Wydawca:

Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS

Opis:

Polish - Japan Issue

Abstrakt:

In recent years, the antisense strategy for cancer therapy has progressed from in vitro culturestudies, to investigations in animal models, and now to clinical studies. We describe here thecurrent state of progress toward gene-directed antisense-based cancer therapy targetingBCR/ABL oncogene, primarily from the viewpoint of initial proof-of-concepts studies in animalmodels of human leukemias and phase I clinical investigations.

Czasopismo/Seria/cykl:

Biotechnologia, vol.35, 4 (1996)-.

Tom:

35

Zeszyt:

4

Strona pocz.:

108

Strona końc.:

115

Szczegółowy typ zasobu:

Article

Format:

application/pdf

Identyfikator zasobu:

0860-7796 ; oai:rcin.org.pl:146559 ; IChB B-31

Źródło:

Library of Institute of Bioorganic Chemistry PAS

Język:

eng

Język streszczenia:

eng

Zakres czasowy:

1988-2010

Prawa:

Creative Commons Attribution BY-SA 4.0 license

Zasady wykorzystania:

Copyright-protected material. [CC BY-SA 4.0] May be used within the scope specified in Creative Commons Attribution BY-SA 4.0 license, full text available at:

Digitalizacja:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Lokalizacja oryginału:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Dofinansowane ze środków:

Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.

Dostęp:

Open